Gold Stocks Continue Run Following Bullish Analyst Report
Is gold really headed to $3,000 per ounce?
The Worst Mistake Amyris Investors Can Make Right Now
The company might have mobilized to respond to the coronavirus pandemic, but investors must focus on whether that results in tangible business progress.
Shares of VBI Vaccines Tumble on Public Offering
The vaccine developer was forced to raise cash at a relatively low offering price, which will result in a significant amount of dilution.
Shares of BioNTech Soar on a Coronavirus Vaccine Announcement
The biotech and its partner, Pfizer, will soon begin the first clinical trials of a coronavirus vaccine in Germany.
Gilead Sciences Races to Manufacture Remdesivir, but Chemistry Has Speed Limits
The biotech is racing to produce remdesivir for as many COVID-19 patients as possible. Will it be enough?
Can U.S. Coal-Fired Power Plants Survive the Coronavirus Pandemic?
The EIA projects electricity generation from U.S. coal-fired power plants in 2020 will fall to 60-year lows.
2 High-Risk, High-Reward Stocks to Add to Your Watch List
These two businesses offer compelling growth potential, but one has yet to deliver on its promise and the other just became more complicated thanks to the coronavirus pandemic.
Electricity Demand in 2020 to Decline By Most Since Great Recession
The EIA expects this to be a rough year for the U.S. power sector, although there will be one bright spot: renewable energy.
2 Stocks to Start Investing in 2020
These utilities won't be spared by the coronavirus pandemic, but they're among the best investments for investors with a long-term mindset.
Here's Why New Gold Jumped as Much as 13% Today
Increasing economic uncertainty has propped up gold prices.
Don't Waste Your Money on Penny Stocks, These 2 Stocks Are Better Buys
These healthcare stocks are risky, but they offer investors much better wealth-building potential than penny stocks.
1 Recent IPO to Add to Your Watch List
This biotech is seeking to understand the immune system to develop insights and drug products for the most vexing health problems, including COVID-19.
Athersys Stock Tumbles as Much as 27.7% on a Public Offering
The stem cell developer decided to wisely take advantage of a soaring share price to raise funds.
Alliance Resource Partners Tumbled as Much as 18.3% Today
The coal producer has taken steps to limit the impact of COVID-19 to its business, but investors remain cautious.
2 Top Small-Cap Stocks to Buy Right Now
These development-stage drug companies are well positioned for success, even amid the current market uncertainty.
Near a 2-Year Low, Is Codexis Stock a Buy?
The small-cap stock has been cut in half in the last year. Is a $650 million market cap too good to pass up?
Invitae Gained as Much as 11.8% Today, but It Might Not Last
Investors might want to be cautious until the medical genetics company issues first-quarter 2020 operating results.
Are There Any Safe Stocks to Buy?
One animal-health leader will help essential businesses and pet owners keep their creatures safe during these uncertain times.
Gold Stocks Are Soaring (Again) on Gloomy Economic Data
Precious metals are gaining on the latest jobs data. Gold and silver stocks are rising with them, but can the gains prove sustainable?
Why Fate Therapeutics Tumbled 23.9% in March
The development-stage pharma company gave up a good chunk of its gains from recent months, but roared back in April.